# A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)

> **NCT00651209** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 105 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Tenofovir

## Key facts

- **NCT ID:** NCT00651209
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2014-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651209, "A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00651209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*